The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene

Lung Cancer

Volumn 81, Issue 3, 2013, Pages 491-494

  Toyokawa, Gouji ^a   Takenoyama, Mitsuhiro ^a   Taguchi, Kenichi ^a   Arakaki, Katsumi ^a   Inamasu, Eiko ^a   Toyozawa, Ryo ^a   Kojo, Miyako ^a   Shiraishi, Yoshimasa ^a   Morodomi, Yosuke ^a   Takenaka, Tomoyoshi ^a   Hirai, Fumihiko ^a   Yamaguchi, Masafumi ^a   Seto, Takashi ^a   Leone, Alvaro ^b   Graziano, Paolo ^b   Ichinose, Yukito ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

EGFR TKI; Epidermal growth factor receptor; Lung carcinosarcoma; Lung sarcomatoid carcinoma; Molecular targeted therapy; Oncogenic drivers

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; ARTICLE; BONE LESION; BRONCHOSCOPY; CANCER STAGING; CARCINOSARCOMA; CASE REPORT; CHONDROSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HOSPITAL DISCHARGE; HUMAN; INFORMED CONSENT; LABORATORY TEST; LOBECTOMY; LUMBAR VERTEBRA; LUNG CARCINOMA; LUNG CARCINOSARCOMA; LUNG METASTASIS; LUNG SARCOMA; MICRODISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; VIDEO ASSISTED THORACOSCOPIC SURGERY; WILD TYPE;

EGFR-TKI; EPIDERMAL GROWTH FACTOR RECEPTOR; LUNG CARCINOSARCOMA; LUNG SARCOMATOID CARCINOMA; MOLECULAR-TARGETED THERAPY; ONCOGENIC DRIVERS;

BIOPSY; CARCINOSARCOMA; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; READING FRAMES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE DELETION; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 84881661113     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.06.013     Document Type: Article

References (13)

1. Travis W., Brambilla E., Muller-Hemerlink H., Harris C.C. WHO classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004, IARC Press, Lyon.
2. Italiano A., Cortot A.B., Ilie M., Martel-Planche G., Fabas T., Pop D., et al. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy. Int J Cancer 2009, 125:2479-2482.
3. Pelosi G., Gasparini P., Cavazza A., Rossi G., Graziano P., Barbareschi M., et al. Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene. Lung Cancer 2012, 77:507-514.
4. Jiang X., Liu Y., Chen C., Zhan Z., Yan Q., Guo Y., et al. The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases. Clin Lung Cancer 2012, 13:288-296.
5. Leone A., Graziano P., Gasbarra R., Paone G., Cardillo G., Mancuso A., et al. Identification of EGFR mutations in lung sarcomatoid carcinoma. Int J Cancer 2011, 128:732-735.
6. AJCC cancer staging manual, 2009, Springer, New York, NY. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
7. Venissac N., Pop D., Lassalle S., Berthier F., Hofman P., Mouroux J. Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease?. J Thorac Cardiovasc Surg 2007, 134:619-623.
8. Martin L.W., Correa A.M., Ordonez N.G., Roth J.A., Swisher S.G., Vaporciyan A.A., et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg 2007, 84:973-980.
9. Koss M.N., Hochholzer L., Frommelt R.A. Carcinosarcomas of the lung: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999, 23:1514-1526.
10. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
11. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
12. Janku F., Garrido-Laguna I., Petruzelka L.B., Stewart D.J., Kurzrock R. Novel therapeutic targets in non-small cell lung cancer. J Thorac Oncol 2011, 6:1601-1612.
13. Bae H.M., Min H.S., Lee S.H., Kim D.W., Chung D.H., Lee J.S., et al. Palliative chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer 2007, 58:112-115.